- Home
- INSW vs CNTA Comparison
INSW vs CNTA Comparison
Compare INSW & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSW
- CNTA
- Stock Information
- Founded
- INSW 1999
- CNTA 2020
- Country
- INSW United States
- CNTA United Kingdom
- Employees
- INSW N/A
- CNTA N/A
- Industry
- INSW Semiconductors
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- INSW Technology
- CNTA Health Care
- Exchange
- INSW Nasdaq
- CNTA Nasdaq
- Market Cap
- INSW 2.0B
- CNTA 2.3B
- IPO Year
- INSW N/A
- CNTA 2021
- Fundamental
- Price
- INSW $38.45
- CNTA $15.16
- Analyst Decision
- INSW Strong Buy
- CNTA Strong Buy
- Analyst Count
- INSW 3
- CNTA 8
- Target Price
- INSW $60.67
- CNTA $23.71
- AVG Volume (30 Days)
- INSW 1.4M
- CNTA 489.7K
- Earning Date
- INSW 02-27-2025
- CNTA 11-12-2024
- Dividend Yield
- INSW 15.01%
- CNTA N/A
- EPS Growth
- INSW N/A
- CNTA N/A
- EPS
- INSW 10.33
- CNTA N/A
- Revenue
- INSW $1,007,734,000.00
- CNTA $6,853,000.00
- Revenue This Year
- INSW N/A
- CNTA N/A
- Revenue Next Year
- INSW $1.61
- CNTA N/A
- P/E Ratio
- INSW $3.72
- CNTA N/A
- Revenue Growth
- INSW N/A
- CNTA N/A
- 52 Week Low
- INSW $32.11
- CNTA $7.38
- 52 Week High
- INSW $65.94
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- INSW 51.17
- CNTA 41.38
- Support Level
- INSW $40.30
- CNTA $14.44
- Resistance Level
- INSW $41.62
- CNTA $17.65
- Average True Range (ATR)
- INSW 1.37
- CNTA 1.01
- MACD
- INSW 0.57
- CNTA -0.21
- Stochastic Oscillator
- INSW 48.44
- CNTA 20.22
About INSW International Seaways Inc.
International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.